Next Article in Journal
Availability of Authorizations from EMA and FDA for Age-Appropriate Medicines Contained in the WHO Essential Medicines List for Children 2019
Next Article in Special Issue
Reply to “Comment on Casiraghi et al. ‘Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis’ 2020, 12, 211”
Previous Article in Journal
Fluconazole and Lipopeptide Surfactin Interplay During Candida albicans Plasma Membrane and Cell Wall Remodeling Increases Fungal Immune System Exposure
Previous Article in Special Issue
Systematic Investigation of the Effect of Non-Ionic Emulsifiers on Skin by Confocal Raman Spectroscopy—A Comprehensive Lipid Analysis
 
 
Editorial

Article Versions Notes

Pharmaceutics 2020, 12(4), 315; https://doi.org/10.3390/pharmaceutics12040315
Action Date Notes Link
article xml file uploaded 1 April 2020 17:23 CEST Original file -
article pdf uploaded. 1 April 2020 17:23 CEST Version of Record https://www.mdpi.com/1999-4923/12/4/315/pdf-vor
article xml file uploaded 3 April 2020 08:13 CEST Update -
article xml uploaded. 3 April 2020 08:13 CEST Update https://www.mdpi.com/1999-4923/12/4/315/xml
article pdf uploaded. 3 April 2020 08:13 CEST Updated version of record https://www.mdpi.com/1999-4923/12/4/315/pdf
article html file updated 3 April 2020 08:14 CEST Original file -
article html file updated 8 May 2020 13:30 CEST Update -
article html file updated 21 July 2022 00:41 CEST Update https://www.mdpi.com/1999-4923/12/4/315/html
Back to TopTop